Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (5,090,321)	$ (3,122,637)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based cost on issuance of warrants	2,874,896
Amortization of debt discount and deferred financing costs	176,659	421,217
Amortization of intangible assets	12,841	12,841
Stock-based compensation	297,360
Depreciation on development equipment		2,538
Change in fair value of derivative	190,841	536,345
Loss on debt extinguishment / conversion	257,810	27,504
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(1,906)	17,162
Accounts payable and accrued expenses	364,499	879,838
Accounts payable to related party	(45,348)	(26,308)
Net cash provided by (used in) operating activities	(962,668)	(1,251,500)
Cash flows from financing activities:
Proceeds from convertible notes		1,613,200
Proceeds from sales of common stock	51,805
Proceeds from convertible debt related to joint venture	500,000
Proceeds from short-term loan, other		120,000
Repayment of short-term loans, others	(60,000)	(50,000)
Repaid to others		(75,000)
Net cash provided by financing activities	491,805	1,608,200
Net increase (decrease) in cash	(470,863)	356,700
Cash - beginning of period	588,769	474,019	$ 474,019
Cash - end of period	117,906	830,719	$ 588,769
Supplemental cash flow information:
Interest paid	100,882	65,754
Income taxes paid